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Abstract
Background: The role of clinical parameters such as systemic inflammatory response syndrome (SIRS) criteria in
predicting the infection remains unclear in cirrhosis patients. The aim was to evaluate the usefulness of
inflammatory markers including C-reactive protein (CRP) and the neutrophil-to-lymphocyte ratio (NLR) for diagnosis
of infection and predicting the outcomes in hospitalized cirrhotic patients.
Methods: The study included 184 cirrhotic patients consecutively hospitalized from 2011 to 2012. The presence of
overt infection and survival was evaluated. CRP concentration, NLR, Model for End-Stage Liver Disease (MELD) score
and the presence of SIRS were assessed.
Results: The main cause of admission was uncontrolled ascites (36.4 %), followed by varix bleeding (23.9 %), and
hepatic encephalopathy (13.6 %). Fifty-eight patients (31.5 %) had overt infection during hospitalization and thirty-two
patients (17.4 %) expired during the follow up period (median 38 months). Ninety-two patients (52.2 %)
fulfilled the SIRS criteria and among them, only 32 patients (38.5 %) had the overt infection. For diagnose of
the infection, baseline CRP concentration was a significant factor compared to the presence of SIRS (odds ratio 1.202,
P = 0.003). For predicting one-month short-term survival, MELD score, NLR and WBC count were significant factors but
in Child-Pugh class C patients, NLR was only an independent factor.
Conclusions: CRP was a significant indicator of infection in hospitalized cirrhotic patients and a NLR was a useful
predictor of 1-month survival, particularly in Child–Pugh class C patients. This study suggests that the inflammatory
markers such as CRP and NLR can help identify cirrhotic patients at risk of unfavorable outcomes.
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Background
In cirrhotic patients, the severity of liver disease is an
important factor influencing the risk of mortality [1, 2].
Systemic inflammation occurs frequently in patients
with advanced cirrhosis [2, 3] and might be associated
with a negative outcome [4]. Bacterial infections can lead
to both a longer hospital stay and increased mortality in
patients with cirrhosis [5–7]. Previous studies have
reported that bacterial infections are present or develop
during hospitalization in around the one-third of hospi-
talized cirrhotic patients [3, 6, 8]. Systemic inflammatory
response syndrome (SIRS) has been strongly suggestive
of the presence of infection and association with poor
outcomes [2, 4, 9]. However, the specific characteristics
of cirrhotic populations, such as hypersplenism, hyper-
ventilation associated with hepatic encephalopathy and
hepatorenal syndrome, increase the difficulty of identify-
ing episodes and the use of beta-blockers may modify
the clinical and biochemical parameters used to identify
SIRS [10]. Thus, the presence of overt infection cannot
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be excluded in patients with cirrhosis who do not meet
the SIRS criteria. Although the liver function markers
such as the Model for End-Stage Liver Disease (MELD)
score is a good factor for survival, it has some limita-
tions to reflect the acute status of hospitalized cirrhotic
patients. Hospitalization in cirrhotic patients would be
required at the decompensated events or infection and
so on. This is why a convenient and easy-to-measure
parameter is needed for predicting the outcomes in the
unstable patients group.
C-reactive protein (CRP), which is synthesized in the
liver, has been identified as an inflammatory marker
[11]. We previously reported the usefulness of CRP in
predicting short-term mortality in patients with hepato-
cellular carcinoma (HCC), and outcomes after liver
transplantation [12, 13]. CRP is also an acute phase
reactant that is suggested to be a marker of the presence
of bacterial infection [14]. The neutrophil-to-lymphocyte
ratio (NLR) has been suggested as a marker of systemic
inflammation and shows the relationship between two
different immune pathways [15]. The neutrophil count
reflects ongoing inflammation, whereas the lymphocyte
count represents the immune regulatory pathway. The
NLR has been used to predict outcomes in patients with
cancer and cardiac disease [15, 16]. It was recently re-
ported to predict the outcomes in patients with HCC,
nonalcoholic fatty liver disease, and liver transplantation
[12, 17, 18], Although clinical risk factors of bacterial in-
fection, such as advanced liver diseases or gastrointes-
tinal bleeding, are well characterized [6, 8, 19–21], data
on both CRP and NLR as serologic markers are scarce
in such patients with advanced diseases. The aim of this
study was to investigate whether CRP and NLR could
significantly improve the diagnostic accuracy of infection
and advance the predictive power of short-term mortal-
ity in a large consecutive cohort of patients, who were
hospitalized due to hepatic events.
Methods
Patients
This was a retrospective observational cohort study per-
formed at a university hospital. The study included a co-
hort of 184 consecutive cirrhotic patients hospitalized in
a tertiary center from September 2011 to September
2012. The diagnosis of cirrhosis was based on liver bi-
opsy or clinically when the patients had at least two of
the following three criteria: an inhomogeneous hepatic
surface with splenomegaly or portal hypertension on
radiological findings; platelet count <100,000/mm3 or
variceal changes on endoscopy [22]. The exclusion
criteria were a previous diagnosis of HCC or extrahe-
patic malignancy and an elective admission to evalu-
ate the suspicion of HCC. This study was approved
by the Office of Human Research Protection Program,
Catholic Medical Centre (CMC OHRP, reference
number; OC13RISI0127) and the need for consent
from participants was waived by the CMC OHRP.
This study was also in accordance with the Helsinki
Declaration of 1975.
The main clinical events for hospitalization such as
uncontrolled ascites, variceal bleeding, hepatic encephal-
opathy, or other signs of hepatic deterioration were
reviewed carefully and evaluated. When there was more
than one main clinical event at admission, the criteria
used to define the main cause of admission were the fol-
lowing: (a) Whenever variceal bleeding was coincident
with other major complications, it was considered the
main cause of admission, (b) In patients with hepatic en-
cephalopathy and other events, the former was consid-
ered the main cause of admission, (c) All the types of
infection were counted and analyzed even if it was a sin-
gle present or co-exist with other clinical events [3].
At admission, patients routinely underwent a physical
examination, laboratory tests, and X-ray of the chest and
abdomen. Laboratory tests included blood chemistry
and blood cell counts including CRP concentration
and ascitic/pleural fluid cell counts. Serum CRP level
was measured as high-sensitivity CRP by an immuno-
turbidimetric assay using the C-Reactive Protein, High
Sensitivity reagent (Beckman Coulter, Inc., Fullerton,
CA, USA; limit of detection, 0.08 mg/L). The NLR
was calculated by dividing the neutrophil count by
the lymphocyte count. All the hospitalized patients
were administered empiric broad-spectrum antibiotics
(ceftriaxone or ciprofloxacin) after initial laboratory
test and physical examination, and the regimen was
modified or stopped according to the results of the
cultures or the infection [7].
During hospitalization, cultures of blood, urine, asci-
tes, pleural effusion, and sputum or swabs were taken
when an infection was suspected. The severity of liver
disease was assessed according to the Child–Pugh class
and the MELD score. Physical examination and labora-
tory tests to measure blood cell counts and chemistry
were daily performed. Depending on the creatinine level,
abdominal ultrasonography or computed tomography
was performed if needed.
Definition of systemic inflammation and infection
SIRS was assessed according to the recommendations of
the American College of Chest Physicians/Society of
Critical Care Medicine Consensus Conference [23].
Patients were considered to have SIRS if they fulfilled
at least two of the following criteria: (a) core temperature
of >38 °C or <36 °C; (b) heart rate of >90 beats/min; (c) re-
spiratory rate of >20 breaths/min; partial carbon monox-
ide pressure (PaCO2) ≤ 32 mmHg or the need of
mechanical ventilation or (d) white blood cell (WBC)
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count of >12,000/mm3 or <4000/mm3, or differential
count showing >10 % immature polymorphonuclear neu-
trophil cells (PMNCs).
The most common bacterial infection in cirrhosis is
known to be spontaneous bacterial peritonitis (SBP),
urinary tract infection, followed in frequency by pneu-
monia, and bacteremia [3, 6, 24]. For this evidence, diag-
nosis of SBP was considered as an ascitic fluid PMNC
count >250/mm3. Urinary tract infection was diagnosed
as a urinary WBC count >10 cells per high-power field
or a positive urine culture [3]. Pneumonia was diagnosed
if there was radiographic evidence of pulmonary infiltra-
tion associated with purulent sputum. Bacteremia was di-
agnosed as a positive blood culture in the absence of any
recognized source of infection [3, 4]. Other infections
such as cellulitis, biliary infection, and enterocolitis were
diagnosed according to clinical, radiological, and bacterio-
logic data. Community-acquired infections were defined
as those that were recognized before admission or within
the first 48 h, and hospital-acquired infections or delayed
infections were diagnosed after this period [3].
Statistical analysis
SPSS version 18 (SPSS Inc., Chicago, IL, USA) was used to
analyze the data. The data was expressed as the mean ± SD
or as the median and range. Logistic regression analysis
was performed to assess significant differences in pre-
dicting 1-month survival and the presence of infec-
tion. Overall survival was calculated from the date of
admission to the date of death or the last follow-up.
For patients undergoing liver transplantation, follow-
up was censored at the time of transplantation. The
factors affecting the survival rate were identified using
Cox’s proportional-hazard model.
Results
Baseline characteristics of hospitalized cirrhotic patients
with and without infection
One hundred eighty-four patients were included in
the study (Table 1): 125 (67.9 %) men with a mean
age of 56.7 ± 11.7 years. The main clinical events for
hospitalization were uncontrolled ascites in 67 patients
(36.4 %), variceal bleeding in 44 patients (23.9 %), and
hepatic encephalopathy in 25 patients (13.6 %), alcoholic
withdrawal seizure in 6 patients (3.2 %). Most patients had
severe liver disease of Child–Pugh class B or C (82.5 %)
and average MELD score was 12.2 ± 7.5.
Fifty-eight of 184 patients (31.5 %) had overt infection
during admission, of whom 49 (85 %) patients were di-
agnosed a community acquired infection. The most
common infections were urinary tract infection (n = 21,
36.2 %) followed by pneumonia/bacteremia (n = 9/9,
Table 1 Baseline characteristics of hospitalized cirrhotic patients with or without infection
Patients with infection Patients without infection P values
(n = 58, 31.5 %) (n = 126, 68.5 %)
Age (year-old) 60.2 ± 12.4 55.0 ± 11.0 0.005
Sex (male, %) 33 (56.9 %) 92 (73 %) 0.030
HBV/HCV/Alc/others 20/3/27/8 31/11/82/2 0.002
Child–Pugh classification (A/B/C) 11/26/21 23/59/44 0.969
MELD score 13.2 ± 8.0 11.9 ± 19.1 0.215
Meet the criteria of SIRS (%) 37 (63.8 %) 59 (46.9 %) 0.032
Body temperature 36.8 ± 0.9 36.3 ± 0.5 0.000
Neutrophil to lymphocyte ratio 8.3 ± 10.1 4.9 ± 6.8 0.027
WBC count (/mm3) 8971.7 ± 5340.8 7362.5 ± 4668.9 0.100
Neutrophil count (% of WBC) 71.8 ± 13.7 65.1 ± 14.0 0.003
Lymphocyte count (% of WBC) 17.8 ± 10.9 23.0 ± 12.1 0.004
CRP (mg/L) 34.1 ± 49.2 11.9 ± 19.1 0.002
Baseline laboratory data
Platelet count (/mm3) 116.8 ± 70.0 105.2 ± 55.3 0.272
Albumin (g/dL) 3.0 ± 0.7 3.0 ± 0.6 0.794
Total bilirubin (mg/dL) 3.3 ± 3.1 3.9 ± 4.6 0.373
Prothrombin time (INR) 1.5 ± 0.6 1.5 ± 0.5 0.937
Creatinine (mg/dL) 1.1 ± 0.9 0.9 ± 0.7 0.118
Na (mEq/L) 132.2 ± 18.3 134.9 ± 12.5 0.223
MELD model for end-stage liver disease, SIRS systemic inflammatory response syndrome, CRP C-reactive protein, INR international normalized ratio
Differences assessed using the Mann–Whitney U test for numerical variables and chi-test for categorical variables
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15.5/15.5 %), SBP (n = 6, 10.3 %), cellulitis/biliary tract
infection/enterocolitis (n = 3/3/3, 5.2/5.2/5.2 %) and
others (n = 4, 6.9 %). The patients with infection were
old and female dominant compared to those without in-
fection. However, the alcohol related cirrhosis in the pa-
tients with infection was less than that in the patients
without infection although it was the most common
cause of underlying liver cirrhosis (Table 1). The number
of patients who met the SIRS criteria at admission was
96 (52.2 %). The patients with infection fulfilled the SIRS
criteria significantly more than those without infection
(63.8 % versus 46.9 %, P = 0.032). Among the SIRS cri-
teria, the body temperature in patients with infection
was significantly higher than those without infection.
Otherwise, heart rate, respiration rate and PaCO2 levels
did not differ between patients with and without infection.
The platelet counts and any other liver panel tests were
not different depending on the presence of infection.
Baseline CRP level predicts the infection in hospitalized
cirrhotic patients
The levels of CRP in patients with infection were signifi-
cantly higher than those without infection (Fig. 1a). In
addition, NLR was significantly higher in patients with
infection than those without, in whom WBC counts
were not different between the two groups (Fig. 1a). Spe-
cifically, the neutrophil count was higher and the
lymphocyte count was lower in cirrhotic patients with
infection than those without (Table 1). However, the
MELD score did not differ depending on infection. Nine
out of 45 patients developed delayed infection after ad-
mission, whose CRP and NLR did not differ compared
to those with community-acquired infection.
For predicting infection using the logistic regression
analysis, old age, female gender, non-alcohol related liver
cirrhosis, the presence of SIRS, high level of CRP and
NLR were significant factors (Table 2). In the multivari-
ate analysis, female gender and high baseline CRP were
predictable risk factors for the infection in hospitalized
cirrhotic patients.
With regard to SIRS, CRP showed the trend to in-
crease in patients showing the SIRS (Fig. 1b). NLR and
MELD score in the patients who met the SIRS criteria
were significantly higher than those who did not
(Fig. 1b). For our cohort, the level of the CRP and the
NLR positively correlated with the Child-Pugh class but
it didn’t show the statistical significance (Fig. 1c).
Neutrophil to lymphocyte ratio predicts the short-term
survival in hospitalized cirrhotic patients
Thirty-two patients expired during the mean follow up
period 429.3 ± 302.4 days, of whom eight patients ex-
pired within one month of admission. Patients with high
MELD had significantly poor survival regardless of the
presence of infection or SIRS (P = 0.000). However, for pre-
dicting one-month survival after the hospitalization, the
baseline NLR as well as MELD score and WBC count was
a significant factor (Table 3). Especially, in the patients with
Child-Pugh class C, a high NLR was an independent pre-
dictor for the one-month survival after admission (Table 3).
Discussion
The hospitalized cirrhotic patients suffer from acute de-
compensated events underlying chronic inflammation
status. The present study revealed that CRP and NLR
are useful diagnostic markers for infection compared to
the SIRS in hospitalized cirrhosis patients. In addition,
the baseline NLR predicted the one-month survival as
did the MELD score in hospitalized cirrhosis patients es-



















Child A Child B Child C
P=0.158 P=0.243 P=0.000
a b c
Fig. 1 a CRP level and NLR were significantly higher in infected patients than uninfected patients. b NLR and MELD score in patients with SIRS
were significantly higher than in those without SIRS. c CRP level, NLR and MELD score increased with progressing Child-Pugh class, but MELD
score only reached the statistical difference. Boxes and bars show the means and 95 % confidence intervals. CRP, C-reactive protein; NLR, neutrophil to
lymphocyte ratio; MELD, model for end-stage liver disease; SIRS, systemic inflammatory response syndrome
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As expected, 82.5 % of the patients in this study had
severe liver disease with Child-Pugh class B or C, and
over half of patients (52.2 %) had SIRS at inclusion. We
know that the patients with advanced cirrhosis have a
spontaneous increased proinflammatory response com-
pared with noncirrhotic patients because of an imbal-
ance between proinflammatory (enhanced) and anti-
inflammatory (inhibited) signaling pathways in immune
cells [2, 25, 26]. However, the specific characteristics of
cirrhotic patients increase the difficulty of identifying
SIRS and the presence of SIRS itself do not directly diag-
nose the infection. Infection was a severe but frequent
(20-60 %) complication with decompensated cirrhosis
although frequently asymptomatic, and accounted for
increased mortality [3, 6]. In present study, 46.8 % of
patients without infection also had SIRS although the
patients with infection had more SIRS than those with-
out infection. In a previous study [27], 46 % of infected
patients with cirrhosis did not have SIRS. Taken to-
gether, not all infected patients with cirrhosis develop
SIRS. The authors focused on new prognostic factors
that could reveal acute status such as infection in
addition to standard MELD score and SIRS.
In the present study, CRP level was an independent
predictor of infection compared to the SIRS and MELD
scores. CRP is an acute-phase reactant synthesized by
hepatocytes in response to inflammation and regulated
by proinflammatory cytokines [28]. In our previous re-
port [29], CRP level was an important factor for survival,
and correlated with unfavorable tumor characteristics of
HCC. The merit of CRP concentration is a simple
marker that can be frequently checked in admitted
patients. In another reports, CRP levels were higher
in patients with SIRS, infection, or alcoholic hepatitis
[8, 14, 30] and CRP was the most useful diagnostic
marker of infection compared with other acute phase
reactants such as the procalcitonin, lipopolysaccharide-
binding protein, sCD14 [14]. In addition, CRP level was
reported associated with a lower response rate to antibi-
otics, a higher mortality rate in cirrhosis patients with SBP
[31]. The present study consists that CRP levels increased
in patients with infection, SIRS and worse liver function
but the most distinguishable increase was shown in
patients with infection. Taken together, our study and
previous studies suggest that the CRP may be a sur-
rogate marker for the early identification of infection
in hospitalized cirrhotic patients [8, 14, 30, 31].
NLR increased in patients with infection and predicted
the short-term outcome in hospitalized cirrhotic pa-
tients. An increased WBC count might mean the pres-
ence of infection, but cirrhotic patients usually have low
Table 2 Logistic regression analysis for predicting the infection




Univariate analysis Multivariate analysis
P values P values Odds ratio 95 % CIs
Age 0.006 0.120 1.024 0.994-1.056
Female 0.031 0.042 2.284 1.030-5.065
Non-alcoholic LC 0.018 0.162 1.727 0.803-3.717
Child-Pugh score 0.976
MELD score 0.216
SIRS 0.034 0.316 1.454 0.700-1.034
CRP 0.001 0.003 1.202 1.007-1.304
NLR 0.019 0.181 1.034 0.985-1.086
WBC 0.086
CI confidence intervals, LC liver cirrhosis, MELD model for end-stage liver
disease, SIRS systemic inflammatory response syndrome, CRP C-reactive
protein, NLR neutrophil-to-lymphocyte ratio
Table 3 Logistic regression analysis for predicting the one-month short survival in the hospitalized cirrhotic patients
Univariate analysis Multivariate analysis
Baseline
variables
Total patients Child–Pugh A and B patients Child–Pugh C patients
(n = 119) (n = 65)




MELD score 0.001 0.161 0.610 0.828-3.131 0.159 1.130 0.954-1.338
CRP 0.122
NLR 0.005 0.269 0.446 0.106-1.866 0.022 1.246 1.032-1.505
WBC 0.011 0.169 1.001 1.000-1.001 0.496 1.000 1.000-1.000
SIRS 0.997
Infection 0.657
OR odds ratio, CI confidence intervals, LC liver cirrhosis, MELD model for end-stage liver disease, CRP C-reactive protein, NLR neutrophil-to-lymphocyte ratio,
SIRS systemic inflammatory response syndrome
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WBC counts due to hypersplenism and patients with al-
coholic cirrhosis show high WBC count even without
infection. In the present study, the simple WBC counts
were not different between infection and no infection
group. However, neutrophil count in the infection group
was higher than no infection group and lymphocyte
count in the infection group was lower than no infection
group. This suggests that NLR is a more powerful pre-
dictor of infection than simple WBC counts. The early
hyperdynamic phase of infection is characterized by a
proinflammatory state, which is associated with suppres-
sion of neutrophil apoptosis [32] and increased lympho-
cyte apoptosis in the thymus and spleen [33]. Recently,
the neutrophil dysfunction was reported even in the
stable cirrhosis patients [34] and predicted outcomes in
cirrhosis and alcohol hepatitis [35]. It might be due to
the deranged phagocytic activity of opsonized bacteria of
neutrophil in advanced cirrhosis. In the present study,
neutrophil also showed the significant difference be-
tween infection and no infection group. Until now, there
is little about the diagnostic power of NLR for infection
in liver cirrhosis even though there are some reports
about the role of NLR in infection among patients with
acute exacerbation of chronic obstructive pulmonary
disease and in emergency department [36, 37]. There-
fore, NLR can be a helpful marker for identifying infec-
tion in hospitalized cirrhotic patients in addition to CRP.
Accumulating data have shown that NLR may be the
outcome predictor of several cancers, cardiac disease
and even in liver disease such as HCC, non-alcoholic
steatohepatitis, liver transplantation waiting patients
[12, 15–18]. Recently, pretreatment NLR was reported
to be associated with the prognosis of patients with
acute on chronic hepatitis B liver failure [38]. However,
there has been not yet clear explanation how elevated
NLR would be responsible for liver cirrhosis patients. As
previously mentioned, in cirrhotic patients, immune and
inflammatory systems are activated and inflammatory
markers, such as interleukin-6 and tumor necrosis factor-
α, have been found to be elevated [39]. Since neutrophil
could also suppress T cell activation through the produc-
tion of arginase, nitric oxide and reactive oxygen species
[40], it induces depletion of lymphocyte-mediated im-
mune response. Therefore, elevated NLR might be a poor
prognostic marker in cirrhosis patients. In a previous re-
port in which the stable cirrhosis patients without infec-
tion or HCC were enrolled, the NLR predicted survival at
12, 24, and 36 months [41]. By contrast, our patients
mostly showed decompensation at admission and NLR
could predict one-month survival especially in patients
with Child-Pugh class C. The overall survival of cirrhotic
patients is influenced by many factors such as liver func-
tion and the presence of life-threatening episodes. There-
fore, the MELD and Child–Pugh scores could predict the
overall survival independent of the presence of infection.
The NLR reflects the interrelationship between the lym-
phomononuclear and neutrophilic arms of the process of
inflammation through complex cytokine interactions [41].
Thus, the NLR is an indicator of the overall inflammatory
status of the body. The NLR was a better predictor of 1-
month survival than 3- or 6-month survival (data not
shown). These findings suggest that NLR reflects the
current inflammatory status at admission and thus may be
useful for predicting short-term survival for 1 month even
in Child–Pugh class C patients whose liver function is
poor. In our previous report, NLR was significantly related
to underlying hepatic reserve as well as tumor burden
[12]. Thus, NLR might be helpful to consider who need
the early liver transplantation in addition MELD score.
Conclusions
In conclusion, CRP and NLR are helpful diagnostic
markers of infection in hospitalized cirrhotic patients. In
Child–Pugh class C patients, an elevated NLR predicted
a poor 1-month survival. Therefore, hospitalized cir-
rhotic patients with an elevated CRP concentration and
NLR should be monitored carefully for the presence of
infection. In addition to the classical MELD score, NLR
may be a useful predictor of the short-term mortality in
hospitalized cirrhotic patients.
Abbreviations
SIRS: Systemic inflammatory response syndrome; MELD: Model for End-Stage
Liver Disease; CRP: C-reactive protein; HCC: Hepatocellular carcinoma;
NLR: Neutrophil-to-lymphocyte ratio; PaCO2: Partial carbon monoxide
pressure; WBC: White blood cell; PMNC: Polymorphonuclear neutrophil cell;
SBP: Spontaneous bacterial peritonitis.
Competing interests
The authors declare that they have no conflict of interest.
Authors’ contributions
JHK and JWJ planned the study design and analyzed and interpreted the
data. JHK and JWJ drafted the manuscript. YWK, SWL and SWN enrolled and
treated patients and acquired the data. DJ and SL performed the laboratory
works. All authors had access to the study data and reviewed and approved
the final manuscript.
Author details
1Department of Internal Medicine, Incheon St. Mary’s Hospital, The Catholic
University of Korea, 56 Dongsu-ro, Bupyeong-gu, Incheon, South Korea.
2Department of Internal Medicine, Seoul St. Mary’s Hospital, The Catholic
University of Korea, 222 Banpo-daero, Seocho-gu, Seoul, South Korea.
3Department of Internal Medicine, Bucheon St. Mary’s Hospital, The Catholic
University of Korea, 327 Sosa-ro, Wonmi-gu, Bucheon-si, Gyeonggi-do, South
Korea. 4Department of Laboratory Medicine, Incheon St. Mary’s Hospital, The
Catholic University of Korea, 56 Dongsu-ro, Bupyeong-gu, Incheon, South
Korea.
Received: 7 May 2015 Accepted: 15 October 2015
References
1. Deschenes M, Villeneuve JP. Risk factors for the development of bacterial
infections in hospitalized patients with cirrhosis. Am J Gastroenterol.
1999;94(8):2193–7.
Kwon et al. BMC Gastroenterology  (2015) 15:146 Page 6 of 7
2. Thabut D, Massard J, Gangloff A, Carbonell N, Francoz C, Nguyen-Khac E,
et al. Model for end-stage liver disease score and systemic inflammatory
response are major prognostic factors in patients with cirrhosis and acute
functional renal failure. Hepatology. 2007;46(6):1872–82.
3. Fernandez J, Navasa M, Gomez J, Colmenero J, Vila J, Arroyo V, et al.
Bacterial infections in cirrhosis: epidemiological changes with invasive
procedures and norfloxacin prophylaxis. Hepatology. 2002;35(1):140–8.
4. Cazzaniga M, Dionigi E, Gobbo G, Fioretti A, Monti V, Salerno F. The
systemic inflammatory response syndrome in cirrhotic patients: relationship
with their in-hospital outcome. J Hepatol. 2009;51(3):475–82.
5. Caly WR, Strauss E. A prospective study of bacterial infections in patients
with cirrhosis. J Hepatol. 1993;18(3):353–8.
6. Borzio M, Salerno F, Piantoni L, Cazzaniga M, Angeli P, Bissoli F, et al.
Bacterial infection in patients with advanced cirrhosis: a multicentre
prospective study. Dig Liver Dis. 2001;33(1):41–8.
7. Wong F, Bernardi M, Balk R, Christman B, Moreau R, Garcia-Tsao G, et al.
Sepsis in cirrhosis: report on the 7th meeting of the International Ascites
Club. Gut. 2005;54(5):718–25.
8. Fernández J, Gustot T. Management of bacterial infections in cirrhosis.
J Hepatol. 2012;56(1):1–12.
9. Abdel-Khalek EE, El-Fakhry A, Helaly M, Hamed M, Elbaz O. Systemic
inflammatory response syndrome in patients with liver cirrhosis. Arab J
Gastroenterol. 2011;12(4):173–7.
10. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, et al.
Definitions for sepsis and organ failure and guidelines for the use of
innovative therapies in sepsis. The ACCP/SCCM Consensus Conference
Committee. American College of Chest Physicians/Society of Critical Care
Medicine. Chest. 1992;101:1644–55.
11. Hurlimann J, Thorbecke GJ, Hochwald GM. The liver as the site of C-reactive
protein formation. J Exp Med. 1966;123(2):365–78.
12. Oh BS, Jang JW, Kwon JH, You CR, Chung KW, Kay CS, et al. Prognostic
value of C-reactive protein and neutrophil-to-lymphocyte ratio in patients
with hepatocellular carcinoma. BMC Cancer. 2013;13:78.
13. An H, Jang J, Bae S, Choi J, Yoon S, Lee M, et al. Serum C-reactive protein is
a useful biomarker for predicting outcomes after liver transplantation in
patients with hepatocellular carcinoma. Liver Transpl. 2012;18(12):1406–14.
14. Papp M, Vitalis Z, Altorjay I, Tornai I, Udvardy M, Harsfalvi J, et al. Acute
phase proteins in the diagnosis and prediction of cirrhosis associated
bacterial infections. Liver Int. 2012;32(4):603–11.
15. Avanzas P, Quiles J, Lopez de Sa E, Sanchez A, Rubio R, Garcia E, et al.
Neutrophil count and infarct size in patients with acute myocardial
infarction. Int J Cardiol. 2004;97(1):155–6.
16. Halazun KJ, Aldoori A, Malik HZ, Al-Mukhtar A, Prasad KR, Toogood GJ, et al.
Elevated preoperative neutrophil to lymphocyte ratio predicts survival
following hepatic resection for colorectal liver metastases. Eur J Surg Oncol.
2008;34(1):55–60.
17. Alkhouri N, Morris-Stiff G, Campbell C, Lopez R, Tamimi TA, Yerian L, et al.
Neutrophil to lymphocyte ratio: a new marker for predicting steatohepatitis
and fibrosis in patients with nonalcoholic fatty liver disease. Liver Int.
2012;32(2):297–302.
18. Leithead JA, Rajoriya N, Gunson BK, Ferguson JW. Neutrophil-to-lymphocyte
ratio predicts mortality in patients listed for liver transplantation. Liver Int.
2015;35(2):502–9.
19. Tandon P, Garcia-Tsao G. Bacterial infections, sepsis, and multiorgan failure
in cirrhosis. Semin Liver Dis. 2008;28(1):26–42.
20. Bernard B, Grange JD, Khac EN, Amiot X, Opolon P, Poynard T. Antibiotic
prophylaxis for the prevention of bacterial infections in cirrhotic patients with
gastrointestinal bleeding: a meta-analysis. Hepatology. 1999;29(6):1655–61.
21. Llach J, Rimola A, Navasa M, Gines P, Salmeron JM, Gines A, et al. Incidence
and predictive factors of first episode of spontaneous bacterial peritonitis in
cirrhosis with ascites: relevance of ascitic fluid protein concentration.
Hepatology. 1992;16(3):724–7.
22. Jang JW, Yoo SH, Kwon JH, You CR, Lee S, Lee JH, et al. Serum hepatitis B
surface antigen levels in the natural history of chronic hepatitis B infection.
Aliment Pharmacol Ther. 2011;34(11–12):1337–46.
23. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, et al.
Definitions for sepsis and organ failure and guidelines for the use of
innovative therapies in sepsis. The ACCP/SCCM Consensus Conference
Committee. American College of Chest Physicians/Society of Critical Care
Medicine. Chest. 1992;101(6):1644–55.
24. Garcia-Tsao G. Bacterial infections in cirrhosis: treatment and prophylaxis.
J Hepatol. 2005;42 Suppl 1:85–92.
25. Albillos A, de la Hera A, Gonzalez M, Moya JL, Calleja JL, Monserrat J, et al.
Increased lipopolysaccharide binding protein in cirrhotic patients with
marked immune and hemodynamic derangement. Hepatology.
2003;37(1):208–17.
26. Ijichi H, Taketomi A, Yoshizumi T, Uchiyama H, Yonemura Y, Soejima Y, et al.
Hyperbaric oxygen induces vascular endothelial growth factor and reduces
liver injury in regenerating rat liver after partial hepatectomy. J Hepatol.
2006;45(1):28–34.
27. Plessier A, Denninger MH, Consigny Y, Pessione F, Francoz C, Durand F,
et al. Coagulation disorders in patients with cirrhosis and severe sepsis.
Liver Int. 2003;23(6):440–48.
28. Castell JV, Gomez-Lechon MJ, David M, Fabra R, Trullenque R, Heinrich PC.
Acute-phase response of human hepatocytes: regulation of acute-phase
protein synthesis by interleukin-6. Hepatology. 1990;12(5):1179–86.
29. Jang JW, Oh BS, Kwon JH, You CR, Chung KW, Kay CS, et al. Serum
interleukin-6 and C-reactive protein as a prognostic indicator in
hepatocellular carcinoma. Cytokine. 2012;60(3):686–93.
30. Cervoni JP, Thevenot T, Weil D, Muel E, Barbot O, Sheppard F, et al.
C-reactive protein predicts short-term mortality in patients with cirrhosis.
J Hepatol. 2012;56(6):1299–304.
31. Cho Y, Park SY, Lee JH, Lee DH, Lee M, Yoo JJ, et al. High-sensitivity
C-reactive protein level is an independent predictor of poor prognosis in
cirrhotic patients with spontaneous bacterial peritonitis. J Clin Gastroenterol.
2014;48(5):444–49.
32. Jimenez MF, Watson RW, Parodo J, Evans D, Foster D, Steinberg M, et al.
Dysregulated expression of neutrophil apoptosis in the systemic
inflammatory response syndrome. Arch Surg. 1997;132(12):1263–69.
33. Wesche DE, Lomas-Neira JL, Perl M, Chung CS, Ayala A. Leukocyte apoptosis
and its significance in sepsis and shock. J Leukoc Biol. 2005;78(2):325–37.
34. Tritto G, Bechlis Z, Stadlbauer V, Davies N, Francés R, Shah N, et al. Evidence
of neutrophil functional defect despite inflammation in stable cirrhosis.
J Hepatol. 2011;55(3):574–81.
35. Mookerjee RP, Stadlbauer V, Lidder S, Wright GA, Hodges SJ, Davies NA, et
al. Neutrophil dysfunction in alcoholic hepatitis superimposed on cirrhosis is
reversible and predicts the outcome. Hepatology. 2007;46(3):831–40.
36. Tanriverdi H, Ornek T, Erboy F, Altinsoy B, Uygur F, Atalay F, et al.
Comparison of diagnostic values of procalcitonin, C-reactive protein and
blood neutrophil/lymphocyte ratio levels in predicting bacterial infection in
hospitalized patients with acute exacerbations of COPD. Wien Klin
Wochenschr. 2015. [Epub ahead of print]
37. Lowsby R, Gomes C, Jarman I, Lisboa P, Nee PA, Vardhan M, et al.
Neutrophil to lymphocyte count ratio as an early indicator of blood stream
infection in the emergency department. Emerg Med J. 2015;32:531–34.
38. Liu H, Zhang H, Wan G, Sang Y, Chang Y, Wang X, et al. Neutrophil-
lymphocyte ratio: a novel predictor for short-term prognosis in acute-on-chronic
hepatitis B liver failure. J Viral Hepat. 2014;21:499–507.
39. Giron-Gonzalez JA, Martinez-Sierra C, Rodriguez-Ramos C, et al. Implication
of inflammation-related cytokines in the natural history of liver cirrhosis.
Liver Int. 2004;24(5):437–45.
40. Muller I, Munder M, Kropf P, Hansch GM. Polymorphonuclear neutrophils
and T lymphocytes: strange bedfellows or brothers in arms? Trends
Immunol. 2009;30(11):522–30.
41. Biyik M, Ucar R, Solak Y, Gungor G, Polat I, Gaipov A, et al. Blood neutrophil-
to-lymphocyte ratio independently predicts survival in patients with liver
cirrhosis. Eur J Gastroenterol Hepatol. 2013;25:435–41.
Kwon et al. BMC Gastroenterology  (2015) 15:146 Page 7 of 7
